OLVIG
BNTX icon

Oliver Lagore Vanvalin Investment Group’s BioNTech BNTX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$8.09K Buy
71
+5
+8% +$571 ﹤0.01% 471
2024
Q3 		$7.84K Buy
+66
New +$6.07K ﹤0.01% 451

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's BNTX Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group increased its BioNTech (BNTX) stake by 7.6% in Q4 2024, buying an estimated $571 and bringing the position to 71 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

Oliver Lagore Vanvalin Investment Group first reported a position in BNTX in Q3 2024 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group held 71 shares of BioNTech worth $8.09K as of Q4 2024.
  • Oliver Lagore Vanvalin Investment Group bought 5 BioNTech shares in Q4 2024, an estimated $571.
  • BioNTech made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q4 2024, its #471 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in BioNTech in Q3 2024 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.